NOTICE OF ANNUAL MEETING
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
o Preliminary Proxy Statement
o Confidential, for Use of the Commission Only (as permitted by Rule14a-6(e)(2))
þ Definitive Proxy Statement
o Definitive Additional Materials
o Soliciting Material Pursuant to §240.14A-12
NET 1 UEPS TECHNOLOGIES, INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
þ
|
|
No fee required. |
|
|
|
|
|
|
|
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange
Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it
was determined): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5)
|
|
Total fee paid: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
o
|
|
Fee paid previously with preliminary materials. |
|
|
|
|
|
|
|
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
Identify the previous filing by registration statement number, or the form or schedule and
the date of its filing. |
|
|
|
|
|
|
|
(1)
|
|
Amount previously paid: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2)
|
|
Form, schedule or registration statement no.: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3)
|
|
Filing party: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(4)
|
|
Date filed: |
|
|
|
|
|
|
|
|
|
|
NET 1 UEPS TECHNOLOGIES, INC.
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
to be held on November 30, 2007
To the Shareholders of Net 1 UEPS Technologies, Inc.:
NOTICE IS HEREBY GIVEN that the 2007 Annual Meeting of Shareholders of Net 1 UEPS
Technologies, Inc., a Florida corporation, will be held at President Place, 6th Floor, Cnr. Jan
Smuts Avenue and Bolton Road, Rosebank, Johannesburg, South Africa on November 30, 2007 at 17h00,
local time, for the following purposes:
|
1. |
|
To elect seven directors. |
|
|
2. |
|
To ratify the selection of Deloitte & Touche (South Africa) as the independent
registered public accounting firm for the fiscal year ending June 30, 2008. |
|
|
3. |
|
To transact such other business and act upon any other matter which may properly come
before the annual meeting or any adjournment or postponement of the meeting. |
Our Board of Directors has fixed the close of business on October 19, 2007 as the record date
for determining shareholders entitled to notice of and to vote at the meeting. A list of the
shareholders as of the record date will be available for inspection by shareholders at our
principal executive offices, which is located at President Place, 6th Floor, Cnr. Jan Smuts Avenue
and Bolton Road, Rosebank, Johannesburg, South Africa during business hours for a period of ten
days prior to the meeting.
Your attention is directed to our annual report for the fiscal year ended June 30, 2007, which
is enclosed with this proxy statement.
|
|
|
|
|
|
|
The Board of Directors, |
|
|
|
|
|
|
|
|
|
Chief Executive Officer,
|
|
|
|
|
Chairman of the Board of Directors |
|
|
Johannesburg, South Africa
October 26, 2007
WE CORDIALLY INVITE ALL SHAREHOLDERS TO ATTEND IN PERSON. HOWEVER,
REGARDLESS OF WHETHER YOU PLAN TO ATTEND THE ANNUAL MEETING, PLEASE
PROMPTLY COMPLETE, SIGN, DATE AND RETURN THE ENCLOSED PROXY CARD IN THE
ENVELOPE PROVIDED. IF YOU ATTEND THE ANNUAL MEETING YOU MAY REVOKE
YOUR PROXY CARD AND VOTE IN PERSON.
NET 1 UEPS TECHNOLOGIES, INC.
President Place, 6th Floor
Cnr. Jan Smuts Avenue and Bolton Road
Rosebank, Johannesburg
South Africa
PROXY STATEMENT
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page |
|
|
|
|
2 |
|
|
|
|
3 |
|
|
|
|
3 |
|
|
|
|
4 |
|
|
|
|
4 |
|
|
|
|
4 |
|
|
|
|
6 |
|
|
|
|
7 |
|
|
|
|
9 |
|
|
|
|
9 |
|
|
|
|
10 |
|
|
|
|
10 |
|
|
|
|
10 |
|
|
|
|
10 |
|
|
|
|
11 |
|
|
|
|
17 |
|
|
|
|
18 |
|
|
|
|
19 |
|
|
|
|
22 |
|
|
|
|
22 |
|
|
|
|
23 |
|
|
|
|
23 |
|
|
|
|
24 |
|
|
|
|
25 |
|
|
|
|
26 |
|
|
|
|
29 |
|
General
This proxy statement is being furnished to shareholders of Net 1 UEPS Technologies, Inc., a
Florida corporation, in connection with the solicitation by our Board of Directors, or the Board,
of proxies for use at the Annual Meeting of Shareholders to be held at President Place, 6th Floor,
Cnr. Jan Smuts Avenue and Bolton Road, Rosebank, Johannesburg, South Africa on November 30, 2007 at
17h00, local time, and at any adjournment or postponement of the annual meeting.
1
INFORMATION CONCERNING SOLICITATION AND VOTING
Solicitation
We will bear the entire cost of the solicitation, including the preparation, assembly,
printing and mailing of this proxy statement, including the proxy card and any additional
solicitation materials furnished to our shareholders. Copies of solicitation materials will be
furnished to brokerage houses, fiduciaries and custodians holding shares in their names that are
beneficially owned by others so that they may forward this solicitation material to such beneficial
owners. We may reimburse these persons for their reasonable expenses in forwarding solicitation
materials to beneficial owners. The original solicitation of proxies by mail may be supplemented by
a solicitation by personal contacts, telephone, facsimile, electronic mail or any other means by
our directors, officers or employees. No additional compensation will be paid to our directors,
officers or employees for performing these services. Except as described above, we do not presently
intend to solicit proxies other than by mail.
This proxy statement and the accompanying solicitation materials are being sent to our
shareholders on or about October 29, 2007.
Revocation of Proxies
You may revoke your proxy at any time prior to the close of the polls at 23h00, Johannesburg
time, on November 29, 2007 by (1) delivering a written notice of revocation or a duly executed
proxy with a later date by mail to our corporate secretary at Net 1 UEPS Technologies, Inc., P O
Box 2424, Parklands 2121, Gauteng, South Africa, or (2) attending the meeting and voting in person.
If you hold shares through a bank or brokerage firm, you must contact that firm to revoke any prior
voting instructions. However, if you are a shareholder whose shares are not registered in your own
name, you will need documentation from your record holder stating your ownership as of October 19,
2007 in order to vote personally at the annual meeting.
Record Date, Quorum and Voting Requirements
Each holder of shares of our common stock and special convertible preferred stock outstanding
on the close of business on October 19, 2007, the record date, is entitled to notice of and vote at
the annual meeting or any adjournment thereof. There were 52,339,194 shares of common stock and
5,389,140 shares of special convertible preferred stock outstanding on the record date. The
presence at the annual meeting, in person or by a proxy, of a majority of the total number of
outstanding shares of common stock and special convertible preferred stock, or 28,864,168 shares,
is necessary to constitute a quorum. Each share of common stock and special convertible preferred
stock is entitled to one vote on all matters to be acted upon at the annual meeting. The common
stock and the special convertible preferred stock vote together as one class. For purposes of the
quorum and the discussion below regarding the vote necessary to take shareholder action, holders of
record of common stock and special convertible preferred stock who are present at the annual
meeting in person or by proxy and who abstain, including brokers holding customers shares of
record who cause abstentions to be recorded at the annual meeting, are considered shareholders who
are present and entitled to vote and they count toward the quorum. In the event that there are not
sufficient votes for a quorum or to approve any proposal at the annual meeting, the annual meeting
may be adjourned in order to permit the further solicitation of proxies.
Brokers holding shares of record for customers generally are not entitled to vote on certain
matters unless they receive voting instructions from their customers. Broker non-votes mean the
votes that could have been cast on the matter in question if the brokers had received instructions
from their customers, and as to which the brokers have notified us on a proxy form in accordance
with industry practice or have otherwise advised us that they lack voting authority.
2
Under the rules that govern brokers who are voting with respect to shares held in a fiduciary
capacity, brokers have the discretion to vote shares on routine matters, but not on non-routine
matters. Routine matters include the election of directors and ratification of independent
registered public accountants.
Broker non-votes are not considered shares entitled to vote on the matter and therefore will
not be taken into account in determining the outcome of the vote on the matter.
All outstanding shares of common stock and special convertible preferred stock represented by
valid and unrevoked proxies received in time for the annual meeting will be voted. Shares will be
voted as instructed in the accompanying proxy on each matter submitted to shareholders. A
shareholder may, with respect to the election of directors (1) vote for the election of the named
director nominees, (2) withhold authority to vote for all such director nominees or (3) vote for
the election of all such director nominees other than any nominee(s) with respect to whom the
shareholder withholds authority to vote by writing such nominees name on the proxy in the space
provided. A shareholder may, with respect to each other matter specified in the notice of meeting
(1) vote FOR the matter, (2) vote AGAINST the matter or (3) ABSTAIN from voting on the
matter. If no instructions are given on a properly completed and returned proxy, the shares will be
voted FOR the election of the named director nominees and FOR the ratification of the selection of
Deloitte & Touche (South Africa) as our independent registered public accounting firm for the
fiscal year ending June 30, 2008.
Our seven nominees will be elected by a plurality of votes. Withholding a vote as to any
nominee is the equivalent of abstaining. In an uncontested election such as this, abstentions have
no effect, since approval by a specific percentage of the shares present or outstanding is not
required. With respect to the proposal to ratify the selection of Deloitte & Touche (South Africa)
as our independent registered public accounting firm, the proposal will be approved if the votes
cast in favor of the proposal exceed the number of votes cast against the proposal, and abstentions
will not be taken into account in determining the outcome of the vote on this proposal.
The Board knows of no additional matters that will be presented for consideration at the
annual meeting. Return of a valid proxy, however, confers on the designated proxy holders the
discretionary authority to vote the shares in accordance with their best judgment on such other
business, if any, that may properly come before the meeting or any adjournment or postponement
thereof. Proxies solicited hereby will be tabulated by inspectors of election designated by the
Board.
PROPOSALS TO BE VOTED ON AT THE ANNUAL MEETING
PROPOSAL NO. 1: ELECTION OF DIRECTORS
The terms of office of each of our current directors will expire at the annual meeting or at
such time as their successors shall be elected and qualified. The Board has determined to nominate
for re-election each of our current directors (see Information Regarding the Board and Board
Committees for information on all directors) for a one-year term expiring at the annual meeting of
shareholders in 2008 or until their successors shall be duly elected and qualified.
The persons named in the enclosed proxy intend to vote properly executed and returned proxies
FOR the election of all nominees proposed by the Board unless authority to vote is withheld. In the
event that any nominee is unable or unwilling to serve, the persons named in the proxy will vote
for such substitute nominee or nominees as they, in their discretion, shall determine. The Board
has no reason to believe that any nominee named herein will be unable or unwilling to serve.
The Board recommends that you vote FOR election of each of its director nominees.
3
PROPOSAL NO. 2: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Audit Committee of our Board has proposed that the firm of Deloitte & Touche (South
Africa), or Deloitte, be selected to serve as independent registered public accounting firm for the
fiscal year ending June 30, 2008. A representative of Deloitte is expected to be present at the
annual meeting. Such representative will have an opportunity to make a statement if he or she
desires to do so and is expected to be available to respond to appropriate questions from
shareholders. Deloitte currently serves as our independent registered public accounting firm.
We are asking our shareholders to ratify the selection of Deloitte as our independent
registered public accounting firm. Although ratification is not required by our by-laws or
otherwise, the Board is submitting the selection of Deloitte to our shareholders for ratification
as a matter of good corporate practice. In the event our shareholders fail to ratify the
appointment, the Audit Committee may reconsider this appointment. Even if the selection is
ratified, the Audit Committee in its discretion may select a different registered public accounting
firm at any time during the year if it determines that such a change would be in our best interests
and the best interests of our shareholders.
The Board recommends a vote FOR ratification of Deloitte.
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
MEMBERS OF THE BOARD
The current members of our Board are as follows:
|
|
|
Dr. Serge C.P. Belamant
54 years old
Director since 1997
Chairman and Chief Executive Officer
|
|
Dr. Serge C.P. Belamant has been
our chief executive officer since
October 2000 and the chairman of
our Board since February 2003.
From June 1997 until June 2004,
Dr. Belamant served as chief
executive officer and a director
of Net 1 Applied Technology
Holdings, or Aplitec, whose
business was acquired by Net 1 in
June 2004. From 1996 to 1997,
Dr. Belamant served as a
consultant in the development of
Chip Off-Line Pre-Authorized Card,
which is a Visa product. From
October 1989 to September 1995,
Dr. Belamant served as the
managing director of Net 1 (Pty)
Limited, a privately owned South
African company specializing in
the development of advanced
technologies in the field of
transaction processing and payment
systems. Dr. Belamant also serves
on the boards of a number of other
companies that perform welfare
distribution services and the
provision of microfinance to
customers. Dr. Belamant spent ten
years working as a computer
scientist for Control Data
Corporation where he won a number
of international awards. Later,
he was responsible for the design,
development, implementation and
operation of the Saswitch ATM
network in South Africa that rates
today as the third largest ATM
switching system in the world.
Dr. Belamant has patented a number
of inventions besides the FTS
patent ranging from biometrics to
gaming-related inventions.
Dr. Belamant has more than 27
years of experience in the fields
of operations research, security,
biometrics, artificial
intelligence and online and
offline transaction processing
systems. Dr. Belamant holds a PhD
in Information Technology and
Management. |
4
|
|
|
Herman Gideon Kotzé
38 years old
Director since 2004
Chief Financial Officer, Secretary
and Treasurer
|
|
Herman Gideon Kotzé has been our
chief financial officer, secretary
and treasurer since June 2004. From
January 2000 until June 2004, he
served on the board of Aplitec as
Group Financial Director. In
mid-1997 until October 1998, Mr.
Kotzé worked for the Industrial
Development Corporation of South
Africa Limited as a business
analyst. Mr. Kotzé served his
articles from 1994 to 1996 at KPMG
in Pretoria, South Africa, and in
1997 he became the audit manager for
several major corporations in the
manufacturing, mining, retail and
financial services industries. Mr.
Kotzé joined Aplitec in November
1998 as a strategic financial
analyst. Mr. Kotzé is a member of
the South African Institute of
Chartered Accountants. |
|
|
|
Christopher Stefan Seabrooke
54 years old
Director since 2005
Chief Executive Officer of Sabvest
Limited
|
|
Christopher Stefan Seabrooke has
been a member of our Board since
January 2005. Mr. Seabrooke has
served on the board of directors of
over twenty listed companies. Mr.
Seabrooke is currently on the board
of directors of the following five
JSE Limited listed companies chief
executive officer of Sabvest
Limited, a finance and investment
group, non-executive chairman of
Metrofile Holdings Limited and
Setpoint Technology Holdings
Limited, non-executive deputy
chairman of Massmart Holdings
Limited and a non-executive director
of Datatec Limited, which is also
listed on AIM in the UK. Mr.
Seabrooke is a member of The
Institute of Directors in South
Africa. Formerly, he was the
chairman of the South African State
Theater and the deputy chairman of
each of the National Arts Council
and the Board of Business and Arts
South Africa. Mr. Seabrooke has
degrees in Economics and Accounting
from the University of Natal and an
MBA from the University of
Witwatersrand. |
|
|
|
Antony Charles Ball
48 years old
Director since 2004
Chief Executive Officer of Brait
Group
|
|
Antony Charles Ball has been a
member of our Board since June 2004.
Mr. Ball has held various senior
leadership positions with the Brait
Group, or Brait, since 1998 and has
been the chief executive officer of
Brait since October 1, 2006. Mr.
Ball has led the raising and
governance of a number of Braits
private equity funds and is
responsible for certain of its
private equity investments. Prior
to assuming his current position at
Brait, Mr. Ball served as joint
deputy chairman of Brait from 1998
to March 2000. Prior to joining
Brait, Mr. Ball was the chief
executive of Capital Partners, which
was the predecessor company to Brait
and which pioneered the private
equity market in South Africa, from
1991 to 1998. Mr. Ball began his
career with Deloitte & Touche
Consulting (1986-1991), where he
co-founded its Strategy Group. Mr.
Ball is a member of the board of
Brait S.A. and its subsidiaries.
Mr. Ball has been designated as a
director by South African Private
Equity Fund III, L.P., an affiliate
of Brait, or SAPEF, pursuant to a
contractual arrangement. |
5
|
|
|
Alasdair J. K. Pein
47 years old
Director since 2005
Director of Southern Cross Capital UK
Limited
|
|
Alasdair Jonathan Kemsley Pein has
been a member of our Board since
February 2005. Mr. Pein is a
director of Southern Cross Capital
UK Limited, which manages
investment funds for Brenthurst
Limited, an investment holding
company for the Oppenheimer family
interests. From 1994 until2002,
Mr. Pein was President and CEO of
Task (USA), Inc., a New York-based
investment company. Mr. Pein also
serves as a director of Arsenal
Digital Solutions, a privately-held
U.S. company that provides
on-demand data protection services.
Between 1989 and 1994, Mr. Pein
worked in London for Bankers Trust
International mergers and
acquisitions team and then at
Gilbert Elliot Corporate Finance.
Mr. Pein is a qualified South
African chartered accountant and
completed his articles with
Deloitte & Touche (South Africa) in
Johannesburg in 1987. Mr. Pein has
been designated as a director by
SAPEF pursuant to a contractual
arrangement. |
|
|
|
Paul Edwards
53 years old
Director since 2005
Executive Chairman of Merryn Capital
|
|
Paul Edwards has been a member of
our Board since July 2005. Mr.
Edwards is the executive chairman
of Merryn Capital, a
privately-owned financial services
group. From 2002 to 2005, Mr.
Edwards was executive chairman of
Chartwell Capital Group. In January
2005, Mr. Edwards was appointed
non-executive chairman of Starcomms
Limited, a Nigerian
telecommunications operator. Prior
to that, Mr. Edwards was the chief
executive officer of MTN Group, a
pan-African mobile operator.
Between 1999 and 2001, Mr. Edwards
was the chief executive officer of
the Johnnic Group in South Africa,
of which the MTN Group was a
subsidiary. Between 1995 and 1999,
Mr. Edwards was the chief operating
officer of MEASAT Broadcast
Network, a Malaysian-based regional
pay television operator. Between
1993 and 1995, Mr. Edwards was
executive vice president of
satellite television broadcaster
Star TV, based out of Hong Kong.
Between 1989 and 1993, Mr. Edwards
was chief executive officer of
Multichoice, Africas leading pay
television operator. Mr. Edwards
has a BSc and an MBA from the
University of Cape Town. |
|
|
|
Florian P. Wendelstadt
40 years old
Director since 2005
Managing Director of General Atlantic
LLC
|
|
Florian P. Wendelstadt has been a
member of our Board since August
2005. Mr. Wendelstadt has been a
Managing Director of General
Atlantic LLC, or GA, a global
private equity firm that provides
capital for growth companies driven
by information technology or
intellectual property, since
December 2000. Mr. Wendelstadt
also serves as a director of
Liberata Limited, TorexRetail Ltd,
Global Collect NV and Saxo Bank
A/S. Mr. Wendelstadt has a BA in
Economics from Passau University in
Germany and a MBA from the European
School of Management. Mr.
Wendelstadt serves as a director on
our Board pursuant to a contractual
arrangement between us and
investment entities affiliated with
GA pursuant to which GA is entitled
to designate one person to serve on
our Board. |
MEETINGS OF THE BOARD AND DIRECTOR INDEPENDENCE
Our Board held meetings on eight occasions during the fiscal year ended June 30, 2007. Each
director attended or participated in more than 75% of the aggregate number of meetings of the Board
and meetings of those committees of the Board on which such director served during the year. It is
our policy to have each director attend the meetings of shareholders. Four of our directors
attended last years annual meeting. The non-management directors meet regularly without any
management directors or employees present. These meetings are held on the same day as the audit
committee or board of director meetings and the chairperson of these meetings is currently Mr.
Seabrooke.
6
The Board has concluded that Messrs. Seabrooke, Pein, Edwards and Wendelstadt are
independent as defined under Nasdaq Rule 4350(c) and under Rule 10A-3(b)(1) under the Securities
Exchange Act of 1934, or the Exchange Act, as that term relates to membership on the Board and the
various Board committees. Mr. Ball is an independent director as defined under Nasdaq rules but
is not eligible to serve on our Audit Committee, under Rule 10A-3(b)(1). The Board has established
an Audit Committee, a Remuneration Committee and a Nominating and Corporate Governance Committee.
The Board has adopted a charter for each of these committees, copies of which are available on our
website at www.net1ueps.com or upon request made by mail to our corporate secretary at Net
1 UEPS Technologies, Inc., P O Box 2424, Parklands 2121, Gauteng, South Africa or by telephone to
our Investor Relations Department at (604) 484-8750.
COMMITTEES OF THE BOARD
The members of our Board Committees are presented in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominating and |
|
|
|
|
|
|
|
|
|
|
Corporate |
|
|
Audit |
|
Remuneration |
|
Governance |
Director |
|
Committee |
|
Committee |
|
Committee |
Antony C. Ball |
|
|
|
|
|
|
X |
|
|
|
X |
|
Dr. Serge C.P. Belamant (#) |
|
|
|
|
|
|
|
|
|
|
|
|
Paul Edwards |
|
|
X |
|
|
|
X |
|
|
|
X |
|
Herman G. Kotzé (#) |
|
|
|
|
|
|
|
|
|
|
|
|
Alasdair J.K. Pein |
|
|
X |
|
|
|
X |
* |
|
|
X |
|
Christopher S. Seabrooke |
|
|
X |
* |
|
|
X |
|
|
|
X |
* |
Florian P. Wendelstadt |
|
|
|
|
|
|
X |
|
|
|
X |
|
|
|
|
# |
|
Executive |
|
* |
|
Chairperson |
Audit Committee
The Audit Committee consists of Messrs. Seabrooke, Pein and Edwards. The Board has determined
that Mr. Seabrooke is an Audit Committee financial expert as that term is defined in applicable
SEC rules, and that all three members meet Nasdaqs financial literacy criteria. The Audit
Committee held eight meetings during the 2007 fiscal year. The Audit Committee was established by
the Board for the primary purpose of overseeing or assisting the Board in overseeing the following:
|
|
|
the integrity of our financial statements; |
|
|
|
|
our compliance with legal and regulatory requirements; |
|
|
|
|
the qualifications and independence of our independent auditors; |
|
|
|
|
the performance of our independent auditors and of the internal audit function; and |
|
|
|
|
our systems and disclosure controls and procedures, internal controls over financial
reporting and compliance with ethical standards adopted by us. |
The Audit Committee operates under a written charter adopted by the Board, which is available
without charge on our website, www.net1ueps.com under the Financial Info Corporate
Governance section.
7
Remuneration Committee
The Remuneration Committee consists of Messrs. Pein, Seabrooke, Edwards, Wendelstadt and Ball.
The Remuneration Committee held four meetings during the 2007 fiscal year. The Remuneration
Committee has the following responsibilities, authority and duties:
|
|
|
assist management in developing and, when appropriate, recommend to the Board the
design of compensation policies, strategies, plans and programs, and disclosure relating
to these matters; |
|
|
|
|
administer our stock option, stock incentive and other equity compensation plans; |
|
|
|
|
review and make recommendations to the Board regarding compensation-related matters
outside the ordinary course, including employment contracts, change-in-control provisions
and severance arrangements; |
|
|
|
|
review and approve performance goals and objectives relevant to the compensation of our
chief executive officer, evaluate the performance of the chief executive officer in light
of those goals and objectives; |
|
|
|
|
make recommendations to the Board regarding director compensation; and |
|
|
|
|
set the compensation of our executive officers. |
The Remuneration Committee operates under a written charter adopted by the Board, which is
available without charge on our website, www.net1ueps.com under the Financial Info
Corporate Governance section.
Nominating and Corporate Governance Committee
The Nominating and Corporate Governance Committee consists of Messrs. Seabrooke, Ball, Pein,
Edwards and Wendelstadt. The Board has determined that each of the members of the committee is
independent in accordance with applicable Nasdaq rules. The Nominating and Corporate Governance
Committee held two meetings during the 2007 fiscal year. The principal duties and responsibilities
of the Nominating and Corporate Governance Committee are as follows:
|
|
|
monitor the composition, size and independence of the Board; |
|
|
|
|
establish criteria for Board and committee membership and recommend to our Board
proposed nominees for election to the Board and for membership on each committee of the
Board; |
|
|
|
|
monitor our procedures for the receipt and consideration of director nominations by
shareholders and other persons and for the receipt of shareholder communications directed
to our Board; |
|
|
|
|
make recommendations regarding proposals submitted by our shareholders; |
|
|
|
|
establish and monitor procedures by which the Board will conduct, at least annually,
evaluations of its performance; |
|
|
|
|
develop and monitor compliance with our corporate governance guidelines; and |
|
|
|
|
make recommendations to the Board regarding management succession planning and
corporate governance best practices. |
The Nominating and Corporate Governance Committee operates under a written charter adopted by
the Board, which is available without charge on our website, www.net1ueps.com under the
Financial Info Corporate Governance section.
8
REMUNERATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
Our Remuneration Committee consists of Messrs. Alasdair J. K. Pein, the committees
chairperson, Christopher S. Seabrooke, Florian P. Wendelstadt and Antony C. Ball. None of the
members of our Remuneration Committee has at any time been one of our officers or employees. None
of our executive officers serves or in the past has served as a member of the board or remuneration
committee of any entity that has one or more of its executive officers serving on our Board or our
Remuneration Committee.
Pursuant to the common stock purchase agreement, dated January 30, 2004, between us and SAPEF,
SAPEF is entitled to designate three nominees to our Board. SAPEF informally agreed to reduce the
number of its designated nominees from three to two due to the reduction in the number of our
shares that SAPEF holds. Messrs. Ball and Pein currently serve on our Board as SAPEFs designees.
Pursuant to the stock purchase agreement, dated July 18, 2005, among the investment entities
affiliated with GA, us and certain other parties, GA is entitled to designate one nominee to our
Board. This designee is currently Mr. Wendelstadt. In addition, pursuant to the stock purchase
agreement, we granted rights, under certain circumstances and subject to certain limitations, with
respect to the registration of our shares held by investment entities affiliated with GA.
NOMINATIONS PROCESS AND DIRECTOR QUALIFICATIONS
The Nominating and Corporate Governance Committee reviews with the Board the skills and
characteristics required of Board members. The committee will consider a candidates independence,
as well as the perceived needs of the Board and the candidates background, skills, business
experience and expected contributions. At a minimum, members of the Board must possess the highest
professional ethics, integrity and values, and be committed to representing the long-term interests
of our shareholders. They must also have an inquisitive and objective perspective, practical
wisdom and mature judgment. The committee may also take into account the benefits of diverse
viewpoints, as well as the benefits of constructive working relationships among directors.
The Nominating and Corporate Governance Committee also reviews and determines whether existing
members of the Board should stand for re-election, taking into consideration matters relating to
the number of terms served by individual directors and the changing needs of the Board. We do not
have a limit on the number of terms an individual may serve as a director on our Board.
The Nominating and Corporate Governance Committee utilizes a variety of methods for
identifying and evaluating nominees for director. The committee regularly assesses the appropriate
composition, size and independence of the Board, and whether any vacancies are expected due to
change in employment or otherwise. In the event that vacancies are anticipated, or otherwise
arise, the committee considers various potential candidates for director. Candidates are evaluated
at regular or special meetings of the Nominating and Corporate Governance Committee, and may be
considered at any point during the year. The committee will consider shareholder recommendations
for candidates for the Board that are properly submitted in accordance with our by-laws in the same
manner it considers nominees from other sources. In evaluating such recommendations, the committee
will use the qualifications standards described above and will seek to achieve a balance of
knowledge, experience and capability on the Board.
9
SHAREHOLDER COMMUNICATIONS WITH THE BOARD
Any shareholder who wishes to communicate directly with the Board may do so via mail or
facsimile, addressed as follows:
Net 1 UEPS Technologies, Inc.
Board of Directors
P O Box 2424
Parklands, 2121
Gauteng, South Africa
Fax: 27 11 880 7080
The corporate secretary shall transmit any communication to the Board as soon as practicable
upon receipt, unless there are safety or security concerns that mitigate against further
transmission. The Board, or individual director(s), as applicable, shall be advised of any
communication as soon as practicable. Absent safety or security concerns, the corporate secretary
shall relay all communications, without any other screening for content.
CORPORATE GOVERNANCE GUIDELINES
The Board has adopted a set of corporate governance guidelines. We will continue to monitor
our corporate governance guidelines and adopt changes as necessary to comply with rules adopted by
the SEC and Nasdaq, and to comport with industry practice. This will include comparing our existing
policies and practices to policies and practices suggested by various groups or authorities active
in corporate governance and the practices of other public companies. A copy of our corporate
governance guidelines is available on our website at www.net1ueps.com.
CODE OF ETHICS
The Board has adopted a written code of ethics, a copy of which is available upon request made
either by mail to our corporate secretary at Net 1 UEPS Technologies, Inc., P O Box 2424, Parklands
2121, Gauteng, South Africa or by telephone to our Investor Relations Department at + 1 604
484-8750. We require all directors, officers, employees, contractors, consultants and temporary
staff to adhere to this code in addressing the legal and ethical issues encountered in conducting
their work. Our code of ethics requires avoidance of conflicts of interest, compliance with all
laws and other legal requirements, conduct of business in an honest and ethical manner, integrity
and actions in our best interest. Directors, officers and employees are required to report any
conduct that they believe in good faith to be an actual or apparent violation of the code. A copy
of our code of ethics is available on our website at www.net1ueps.com. The Sarbanes-Oxley
Act of 2002 requires companies to have procedures to receive, retain and treat complaints received
regarding accounting, internal accounting controls or auditing matters and to allow for the
confidential and anonymous submission by employees of concerns regarding questionable accounting or
auditing matters. We currently have such procedures in place.
COMPENSATION OF DIRECTORS
Directors who are also executive officers do not receive separate compensation for their
services as directors. Certain directors who are not executive officers receive compensation as
described below.
Mr. Seabrooke received annual compensation of USD74,300 (ZAR 525,000) for his services as a
non-executive director and chairman of various of our Board committees for the year ended June 30,
2007. The Remuneration Committee has approved annual compensation of USD100,000 for Mr. Seabrookes
services for the year ending June 30, 2008. Upon his appointment to the Board in 2005, Mr.
Seabrooke received options to purchase 41,667 shares of our common stock.
10
Mr. Edwards received annual compensation of USD51,300 (ZAR 367,500) for his services as
non-executive director for the year ended June 30, 2007. The Remuneration Committee has approved
annual compensation of USD65,000 for Mr. Edwards services for the year ending June 30, 2008. Upon
his appointment to the Board in 2005, Mr. Edwards received options to purchase 41,667 shares of our
common stock.
Compensation paid to Messrs. Seabrooke and Edwards was determined after analyzing the annual
compensation of non-executive directors of U.S.-listed transaction processor companies with market
capitalizations comparable to ours. The analysis for the 2008 fiscal year was performed in August
2007 and the peer group comprised: Moneygram International, Heartland Payments, Global Payments,
Inc., Wright Express Corp., and Euronet Worldwide, Inc. The peer group composition used for
determining our non-executive directors compensation is different from the peer group used to
determine our executive officers compensation as discussed in the Compensation Discussion and
Analysis portion of this proxy statement because of the consolidation in the payment processor
sector which has occurred since February 2007 when our executive officers compensation was
determined. Messrs. Seabrooke and Edwards receive a fixed annual fee for their services.
Messrs. Ball and Pein serve as directors pursuant to an agreement between us and investment
entities affiliated with Brait S.A. Upon their appointment to the Board in 2005, each of Mr. Ball
and Mr. Pein received options to purchase 41,667 shares of our common stock.
Mr. Wendelstadt serves as a director pursuant to an agreement between us and investment
entities affiliated with GA. Under this agreement, we are required to reimburse Mr. Wendelstadts
travel and accommodation expenses incurred in connection with his attendance at our Board and
committee meetings. Although Mr. Wendelstadt traveled regularly to attend meetings, he did not
claim any reimbursements in the fiscal 2007 year.
COMPENSATION DISCUSSION AND ANALYSIS
Overview
The goal of our executive compensation program is the same as our goal for operating the
companyto create long-term value for our shareholders. To achieve this goal, we seek to reward our
executive officers for sustained financial and operating performance and leadership excellence, to
align their interests with those of our shareholders and to encourage them to remain with us for
long and rewarding careers. This section of the proxy statement explains how our compensation
program is designed and operates in practice with respect to the four individuals who comprise our
executive officersour Chief Executive Officer, our Chief Financial Officer, our Senior Vice
President-Marketing and Sales and our Senior Vice President-Information Technology. Our executive
officers have the broadest job responsibilities and are the only individuals who have policy-making
authority.
Each element of our executive compensation program is designed to fulfill one or more of our
performance, alignment and retention objectives. These elements consist of salary, bonus and both
equity and non-equity incentive compensation. In determining the type and amount of compensation
for each executive officer, we focus on both current pay and the opportunity for future
compensation and seek to combine compensation elements so as to optimize his or her contribution to
us. We adjust the mix of our compensation components from year to year based on our overall
performance, an executives individual contributions and compensation practices of other US and
South African public companies including companies in our peer group described below. We do not
have an exact formula for allocating between cash and non-cash compensation. We do, nonetheless,
provide for a balanced mix of compensation components that are designed to encourage and reward
behavior that promotes shareholder value in both the short and long-term.
11
Compensation Objectives
Performance. Each of our executive officers has had a long and distinguished career with us.
We reward excellent performance by our executive officers and motivate them to continue to produce
superior, long-term results through a combination of cash bonuses, incentive payments that depend
on achievement of pre-defined levels of financial and operating goals and equity awards in the form
of stock options or restricted stock that derive their value from increases in our share price
and/or satisfaction of other financial performance goals. Base salary, bonus and non-equity
incentive compensation are designed to reward annual achievements and be commensurate with each
executive officers scope of responsibility, demonstrated ingenuity, dedication and leadership and
management effectiveness. Equity incentive compensation focuses on achievement of longer term
results.
Alignment. We seek to align the interests of our executive officers with our shareholders by
evaluating them on the basis of financial and non-financial measurements that we believe correlate
to long-term shareholder value. Financial measures include growth in revenues, EBITDA and earnings
per share (on both a South African rand and U.S. dollar basis), while non-financial measures
include international expansion of our UEPS technology and the achievement of strategic operational
goals. The elements of our compensation package that we believe align these interests most closely
are stock option awards which increase in value as our stock price increases and restricted stock
awards which vest over time and upon the satisfaction of our performance goals.
Retention. Management and the Remuneration Committee recognize that the talent pool in South
Africa is more limited than in other more developed countries. Therefore, retention is a key
objective of our executive compensation program. We attempt to retain our key employees, including
our executive officers, by seeking to provide a competitive pay package and using continued service
as a condition to receipt of full compensation. The extended vesting terms of stock options and
restricted stock awards have the effect of tying this element of compensation to continued service
with us.
Implementing our Objectives
Process for Determining Compensation. A substantial amount of the Remuneration Committees
responsibilities and efforts relate to the determination of compensation for our executive
officers. The Remuneration Committee obtains compensation data compiled from executive compensation
surveys as well as data gathered from annual reports and proxy statements of companies that it
selects as a peer group for executive compensation analysis purposes. The Remuneration
Committees goal is that the total cash compensation for our executive officers be at the 75th
percentile and the overall equity compensation for executive officers should be within the range of
the 50th to 75th percentiles when our financial performance equals the average of our peer group
companies. Because of the high proportion of cash compensation that is at risk, the Remuneration
Committee reserves the right to adjust total cash compensation to be higher or lower, when our
financial performance exceeds that of our peer group companies or is lower than that of our peer
group companies, as the case may be. Our peer group consists of payment processing companies
generally considered comparable to us as well other companies within the information technology
sector and those engaged in emerging markets. The Remuneration Committees intent generally is to
choose peer group members that have one or more attributes significantly similar to us, such as
that of being a payment systems provider. Our peer group, which includes both United States and
United Kingdom listed companies, consists of the following companies: Ceridian Corporation,
Checkfree Services Corp., Global Payments, Inc., MoneyGram International, Datatec Ltd. and
Dimension Data Holdings Plc.
12
The Remuneration Committees process for determining compensation includes an analysis, for
each executive officer, of all elements of compensation. The Remuneration Committee compares these
compensation components separately and in total to compensation at the peer group companies. The
Remuneration Committee sets the compensation of our Chief Financial Officer based on the total
compensation package of our Chief Executive Officer. Specifically, the Remuneration Committees
goal is to set our Chief Financial Officers compensation at approximately 35-40% of our Chief
Executive Officers total compensation package. Each of our other executive officers compensation
is then set at approximately 50% of the compensation of our Chief Financial Officer. Because the
Remuneration Committee considers international comparables in its compensation analysis for both
our Chief Executive Officer and Chief Financial Officer, their total compensation packages are
denominated in U.S. dollars but paid in South African Rand at the exchange rate in effect at the
time of payment. Our other executive officers compensation packages are also denominated in U.S.
dollars and paid in South African Rand at the exchange rate in effect at the time of payment. In
the first and second quarters of each year, the Remuneration Committee establishes base salaries
and sets the short term variable bonus remuneration targets and payment criteria, as well as how
the achievement of such criteria affects the achievement of variable compensation. Following the
end of each fiscal year, the Remuneration Committee determines the annual incentive cash payments
and bonuses, if any, to be made to each executive officer based on their and our performance during
the fiscal year.
Before the Remuneration Committee makes decisions on compensation for the year, it discusses
with our Chief Executive Officer each executive officers performance during the year, his or her
accomplishments and specific areas of progress. Our Chief Executive Officer bases his evaluation
on his knowledge of each executive officers performance (with due regard to the operational
environment) and targets that have been set for a particular performance period. The executive
officers are then evaluated based on their individual performance during the fiscal year. The
Chief Executive Officer makes a recommendation to the Remuneration Committee on each executive
officers compensation, except for his own and the Chief Financial Officers compensation.
Executive officers do not propose or seek approval for their own compensation. Our Chief Executive
Officers and Chief Financial Officers annual performance review is developed by the Remuneration
Committee as a whole. For our Chief Executive Officers and Chief Financial Officers reviews,
formal feedback is received from the independent directors.
The independent directors perform reviews, which are completed and presented to the Chief
Executive Officer before the Remuneration Committee determines base salary, bonus and incentive
award targets and equity awards. In determining base salary, target bonus amounts and equity
awards, the Remuneration Committee reviews our performance as well as individual performance
information and our peer group executive compensation data.
The Remuneration Committee also consults with management regarding non-executive officer
employee compensation and is responsible for approving all awards under our Amended and Restated
2004 Stock Incentive Plan.
13
Equity Grant Practices. We believe that long-term performance is achieved through a culture
that encourages such performance by our executive officers through the use of stock and stock-based
awards. Accordingly, awards of stock options and restricted stock are a fundamental element in our
executive compensation program because they emphasize long-term performance, as measured by
creation of shareholder value, and foster a commonality of interest between shareholders and
employees. We have granted equity awards primarily through our Amended and Restated 2004 Stock
Incentive Plan, which was adopted by our Board of Directors and approved by our shareholders, to
permit the grant of stock options and other stock-based awards to our employees, directors and
consultants. Options granted under the said plan vest ratably over a period of five years after
grant unless otherwise provided in a particular award agreement and have ten-year terms from the
date of grant. In determining the size of an equity award to an executive officer, the Remuneration
Committee considers the executives then current total compensation package (which includes salary,
potential bonus and cash incentive plan compensation), any previously received equity awards, the
value of the grant at the time of award and the number of grants available for executive
compensation pursuant to our Amended and Restated 2004 Stock Incentive Plan. As discussed in more
detail below under Elements of 2007 Compensation, the Remuneration Committee has not yet
established a regular cycle of equity grants. Since we became a Nasdaq-listed company in August
2005, the Remuneration Committee has approved one grant of options to executive officers and other
employees (in August 2006) and one grant of restricted stock to executive officers and other
employees (in August 2007).
We adopted FASB Statement No. 123 (revised 2004), Share-Based Payments (FAS 123R) at the
beginning in fiscal 2006 and, therefore, record stock-based compensation charges over the vesting
term of the equity award. When awarding equity compensation, management and the Remuneration
Committee seek to weigh the cost of these grants with their potential benefits as a compensation
tool. We believe that combining grants of stock options and restricted stock effectively balances
our objective of focusing our employees, including our executive officers, on delivering long-term
value to our shareholders, with our objective of providing value to our employees with the equity
awards. Stock options have value only to the extent that our stock price on the date of exercise
exceeds the stock price on the date of grant, and thus are an effective compensation tool only if
the stock price appreciates during the vesting term. In this sense, stock options are a
motivational tool. Awards of restricted stock that include financial performance-based vesting
over a stated period of time not only serve to encourage retention and motivate our employees for
superior performance but also mitigate the effects of share price volatility and changes in the
currency exchange rates. Such changes in the currency exchange rates affect our reported results
of operations because our functional currency is the South African Rand and we report in U.S.
dollars.
No Employment Agreements. Our executive officers are employed on an at will basis, without
employment agreements, severance payment arrangements (except as required by local labor laws), or
payment arrangements that would be triggered by a change in control. The absence of such
arrangements enables us to terminate the employment of our executive officers with discretion as to
the terms of any severance arrangement. This is consistent with our performance-based employment
and compensation philosophy. We do have restraint of trade agreements with each of our executive
officers. The terms of these agreements provide that upon the termination of the executives
employment, the executive is restricted, for a period of 24 months, from soliciting business from
certain customers, working for or holding interests in our competitors or participating in a
competitive activity within the territories where we do business.
14
Considerations Regarding Tax Deductibility of Compensation. Section 162(m) of the U.S. tax
code places a limit of $1 million on the amount of compensation that we may deduct in any one year
with respect to each of its executive officers (other than the Chief Financial Officer, to whom
these limits do not currently apply). Certain qualified performance-based compensation is not
subject to this deduction limit. Our stock option awards under the Amended and Restated 2004 Stock
Incentive Plan have been structured with the intention that the compensation the executives will
realize when the stock options are exercised will be qualified performance-based compensation not
subject to the limitations imposed by Section 162(m). However, to maintain flexibility in
compensating our executive officers in a manner designed to promote our various corporate goals, it
is not a policy of the Remuneration Committee that all executive compensation must be
tax-deductible. For example, the bonuses and non-equity incentive compensation payments made to our
executive officers are not qualified performance-based compensation and may be subject to the tax
deduction limitations imposed by Section 162(m). Similarly, the restricted stock granted to our
executive officers, the vesting of which is conditioned upon satisfaction our performance goals,
may be subject to the tax deductibility limitations imposed by Section 162(m) because the
Remuneration Committee retained flexibility to adjust the performance goals to reflect
extraordinary events. The Remuneration Committee believes that the importance of retaining this
flexibility outweighs the benefits of tax deductibility.
Compensation Consultants. Neither we nor the Remuneration Committee have any contractual
arrangement with any compensation consultant or used the services of any compensation consultant
who has a role in determining or recommending the amount or form of executive officer compensation.
Elements of 2007 Compensation
There are four elements that comprised our compensation program in fiscal 2007: (i) base
salary; (ii) cash incentive awards for our Chief Executive Officer and Chief Financial Officer;
(iii) bonus and (iv) equity incentive awards. In addition, we cover all costs for security guards
for our Chief Executive Officer. We did not provide any other type of compensation, retirement,
healthcare, or welfare benefits to any of our executive officers.
Base Salary. Salaries for fiscal 2007 were set in November 2006 after a review of our peer
group companies described above. The 2007 base salaries were set in accordance with the peer group
analysis discussed above. However, in January 2007, the Remuneration Committee approved an
increase in our Chief Executive Officers base salary after reviewing compensation data of chief
executive officers of comparable companies, including those in our peer group.
15
Cash Incentive Awards. During fiscal 2007, the Remuneration Committee established a cash
incentive plan for the Chief Executive Officer and the Chief Financial Officer pursuant to which
these officers became eligible to receive a cash incentive payment of up to 100% and 75%,
respectively, of their respective annual salaries upon the achievement of certain performance
targets with respect to the 2007 fiscal year. In determining the cash incentive awards for the
Chief Executive Officer and Chief Financial Officer, the Remuneration Committee set certain
separate quantitative and qualitative criteria for each such executive officer. With respect to
the Chief Executive Officer, 60% of the cash incentive award was based on pure EPS growth of 20% -
25% (after reversing the stock-based compensation charge, amortization of intangible assets and
costs related to an acquisition that we ultimately decided not to pursue) with a weighting between
USD and ZAR, respectively, of 60%/40%. The Remuneration Committee determined that 40% of the cash
incentive award to be granted to the Chief Executive Officer would be based on the achievement of
certain qualitative goals including: (i) achievement of operational milestones, (ii) the successful
integration of key staff, (iii) appointment of a chief operating officer and (iv) further
international progress. Likewise, with respect to the Chief Financial Officer, 70% of the cash
incentive award was based on pure EPS growth of 20% 25% (after reversing the stock-based
compensation charge, amortization of intangible assets and costs related to an acquisition that we
ultimately decided not to pursue) with a weighting between USD and ZAR, respectively, of 60%/40%.
The Remuneration Committee also determined that 30% of the cash incentive award to be granted to
the Chief Financial Officer would be based on the achievement of certain qualitative goals
including: (i) integration of Prism Holdings senior accounting staff into our operations, and (ii)
the successful performance of such tasks as the Chief Executive Officer may reasonably require of
the Chief Financial Officer.
Following the end of fiscal 2007, the Remuneration Committee determined that the quantitative
requirements had been satisfied and that the qualitative requirements had been sufficiently
achieved by each of the Chief Executive Officer and the Chief Financial Officer to justify full
cash incentive awards, which were subsequently paid in September 2007. Aside from our achieving the
required EPS growth, the Remuneration Committee also considered certain qualitative achievements in
the 2007 fiscal year in its decision to grant the full cash incentive awards to the Chief Executive
Officer and the Chief Financial Officer which included (i) advancements in international growth
such as the implementation of new UEPS systems, particularly in developing economies outside our
current markets in South Africa, (ii) operational efficiencies in South Africa, (iii) guidance and
input provided in the SASSA tender response and (iv) time spent by our executives on the
acquisition we ultimately decided not to pursue.
The Remuneration Committee has tentatively agreed to similar quantitative requirements for the
2008 fiscal year and is in the process of finalizing the qualitative requirements for the 2008
fiscal year.
Bonus. Bonuses may be awarded for accomplishments during the previous fiscal year and are
designed to be commensurate with the executives scope of responsibilities, demonstrated leadership
abilities, management experience and effectiveness. Likewise, with respect to the Chief Executive
Officer and the Chief Financial Officer, bonuses may be paid for performance based on factors
external to the ones considered in determining the payment of the cash incentive awards described
above. Bonuses are determined by the Remuneration Committee with advice from management, based upon
the Remuneration Committees assessment of the individuals contributions during the year, compared
to, but not limited to, a list of individualized goals previously approved by management and the
Remuneration Committee. The goal of this element of compensation focuses on motivating and
challenging the executive to achieve superior, longer term, sustained results. The Remuneration
Committee did not grant any bonus awards in the 2007 fiscal year to our Chief Executive Officer and
Chief Financial Officer as it is of the opinion that the cash incentive awards adequately
compensated these executives. Our Vice-President Sales and Marketing and Vice-President
Information Technology received bonuses as a result of their contributions to our advancements in
international growth and development of new innovative products.
16
Equity Incentive Awards. On August 24, 2006, our executive officers were awarded stock
options to purchase an aggregate of 160,000 shares of our stock under the Plan in the amounts
indicated in the section below entitled Grants of Plan-Based Awards in 2007 Fiscal Year. In
addition, employees who were not executive officers received grants of stock options to purchase
409,120 shares. All of these awards were contingent upon shareholder approval, which was obtained,
of an amendment and restatement of our 2004 Stock Incentive Plan, which, among other things,
increased the number of shares available for grant thereunder. The August 2006 grants represented
the first equity awards granted since June 2004 when we completed the acquisition of Aplitec.
After the 2004 grants, there remained no additional shares available for grant under the 2004 Stock
Incentive Plan. The August 2006 grants were approved at a regularly scheduled meeting of the
Remuneration Committee at which time the Committee also approved an increase in the number of
shares available under the 2004 Stock Incentive Plan, subject to shareholder approval.
The stock options granted in August 2006 vest in 20% increments on May 8th of 2007, 2008,
2009, 2010 and 2011, so long as the recipient remains employed with us through the applicable
vesting date. In August 2007, the Remuneration Committee approved grants of 591,500 shares of
restricted stock (145,000 shares of which were granted to the executive officers). The primary
purpose of these grants was to encourage retention and reward our positive financial performance.
One-third of the award shares will vest on each of September 1, 2009, 2010 and 2011. Vesting of the
award shares is conditioned upon each recipients continuous service through the applicable vesting
date and our achieving the financial performance target set for that vesting date. The vesting
provisions of the August 2006 stock option awards and the August 2007 restricted stock awards are
described more fully below the Grants of Plan-Based Awards Table on page 19 of this proxy
statement.
REMUNERATION COMMITTEE REPORT
For the Year Ended June 30, 2007
The Remuneration Committee, which comprises all the independent directors, has reviewed and
discussed the Compensation Discussion and Analysis section of this proxy statement with
management, including the Chief Executive Officer, Dr. Serge C.P. Belamant, and the Chief Financial
Officer, Herman G. Kotzé. Based on this review and discussion, the Remuneration Committee
recommended to our Board of Directors that the Compensation Discussion and Analysis section be
included in our Annual Report on Form 10-K and this proxy statement.
|
|
|
|
|
Remuneration Committee |
|
|
Alasdair J.K. Pein |
|
|
Christopher Stefan Seabrooke |
|
|
Antony Charles Ball |
|
|
Paul Edwards |
|
|
Florian P. Wendelstadt |
The following narrative, tables and footnotes describe the total compensation earned during
fiscal 2007 by our executive officers. The total compensation presented below in the Summary
Compensation Table does not reflect the actual compensation received by our executive officers in
fiscal 2007 or the target compensation of our executive officers in fiscal 2007. The actual value
realized by our executive officers in fiscal 2007 from long-term equity incentives (options and
restricted stock) is presented in the Options Exercised and Stock Vested Table on page 22 of this
proxy statement. Target annual incentive awards for fiscal 2007 are presented in the Grants of
Plan-Based Awards table on page 19 of this proxy statement. The amounts reflected in the Summary
Compensation Table for stock awards and option awards are the non-cash expense recognized by us for
financial statement reporting purposes with respect to fiscal 2007 for all such awards, including
those granted in prior fiscal years, in accordance with FAS 123R.
17
SUMMARY COMPENSATION TABLE (1)
The following table sets forth the compensation earned by our Chief Executive Officer, our
Chief Financial Officer and our two other executive officers for services rendered during the 2007
fiscal year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive |
|
All |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan |
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
Option |
|
Compen- |
|
Compen- |
|
|
|
|
Salary |
|
Bonus |
|
Awards |
|
sation |
|
sation |
|
|
Name and |
|
($000) |
|
($000) |
|
($000) |
|
($000) |
|
($000) |
|
Total |
Principal Position |
|
(2) |
|
(3) |
|
(4) |
|
(3) |
|
(5) |
|
($000) |
Dr. Serge Belamant, Chief
Executive Officer,
Chairman of the Board and
Director |
|
|
725 |
|
|
|
|
|
|
|
79 |
|
|
|
725 |
|
|
|
39 |
|
|
|
1,568 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Herman Kotzé, Chief
Financial Officer and
Director |
|
|
350 |
|
|
|
|
|
|
|
35 |
|
|
|
263 |
|
|
|
|
|
|
|
648 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brenda Stewart,
Vice-President Sales
and Marketing |
|
|
260 |
|
|
|
65 |
|
|
|
25 |
|
|
|
|
|
|
|
|
|
|
|
350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nitin Soma, Vice-President
Information Technology |
|
|
230 |
|
|
|
58 |
|
|
|
20 |
|
|
|
|
|
|
|
|
|
|
|
308 |
|
|
|
|
(1) |
|
Includes only those columns relating to compensation awarded to, earned
by, or paid to the executive officers in fiscal 2007. All other columns
have been omitted. |
|
(2) |
|
The applicable amount for each executive officer is denominated in USD
and paid in ZAR at the exchange rate in effect at the time of payment. |
|
(3) |
|
Bonus and non-equity incentive plan compensation represent amounts
earned for the fiscal year ended June 30, 2007 and paid in September
2007. The amounts for each executive officer are denominated in USD,
however, 50% of the bonus and non-equity incentive plan is paid in USD
and the remaining 50% is paid in ZAR at the exchange rate in effect at
the time of payment. |
|
(4) |
|
Represents actual stock-based compensation charge related to stock
options granted under the Amended and Restated 2004 Net 1 UEPS
Technologies, Inc. Stock Incentive Plan on August 24, 2006 to the
executive officers. The amounts are valued based on the grant date fair
value of the award determined under FAS 123R. See note 14 to the
Consolidated Financial Statements included in our Annual Report on Form
10-K for the year ended June 30, 2007 for the relevant assumptions used
in calculating grant date fair value under FAS 123R. For further
information on these awards, see the Grants of Plan-Based Awards Table
on page 19 of this proxy statement. |
|
(5) |
|
Represents costs for security guards which is paid in South African Rand. |
18
GRANTS OF PLAN-BASED AWARDS
The following table provides information concerning awards under our Amended and Restated 2004
Stock Incentive Plan and non-equity incentive awards granted during fiscal 2007 to each of our
executive officers.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair |
|
|
|
|
|
|
|
|
Estimated Future |
|
Estimated Future |
|
|
|
|
|
All Other |
|
|
|
|
|
Value |
|
|
|
|
|
|
|
|
Payouts |
|
Payouts |
|
All Other |
|
Option |
|
|
|
|
|
of |
|
|
|
|
|
|
|
|
Under Non-Equity |
|
Under Equity |
|
Stock |
|
Awards: |
|
Exercise |
|
Stock |
|
|
|
|
|
|
|
|
Incentive |
|
Incentive Plan |
|
Awards: |
|
Number of |
|
or Base |
|
and |
|
Market |
|
|
|
|
|
|
Plan Awards |
|
Awards |
|
Number |
|
Securities |
|
Price of |
|
Option |
|
Close |
|
|
|
|
|
|
Thres- |
|
|
|
|
|
Maxi- |
|
Thres- |
|
|
|
|
|
Maxi- |
|
of Shares |
|
Under- |
|
Option |
|
Awards |
|
Price |
|
|
Grant |
|
hold |
|
Target |
|
mum |
|
hold |
|
Target |
|
mum |
|
of Stock |
|
lying |
|
Awards |
|
($000) |
|
($/Sh) |
Name |
|
date(1) |
|
($000) |
|
($000) |
|
($000) |
|
($000) |
|
($000) |
|
($000) |
|
or Units |
|
Options |
|
($/Sh) |
|
(4) |
|
(5) |
Dr. Serge
Belamant |
|
|
8/24/2006 |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
|
|
|
|
80,000 |
|
|
$ |
22.51 |
|
|
|
438 |
|
|
|
24.15 |
|
(2) |
|
|
2/07/2007 |
|
|
|
290 |
|
|
|
725 |
|
|
|
725 |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Herman Kotzé |
|
|
8/24/2006 |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
|
|
|
|
35,000 |
|
|
$ |
22.51 |
|
|
|
192 |
|
|
|
24.15 |
|
(3) |
|
|
2/07/2007 |
|
|
|
79 |
|
|
|
263 |
|
|
|
263 |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brenda Stewart |
|
|
8/24/2006 |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
|
|
|
|
25,000 |
|
|
$ |
22.51 |
|
|
|
137 |
|
|
|
24.15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nitin Soma |
|
|
8/24/2006 |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
n/a |
|
|
|
|
|
|
|
20,000 |
|
|
$ |
22.51 |
|
|
|
110 |
|
|
|
24.15 |
|
|
|
|
(1) |
|
All the options reflected in this table were granted on August 24, 2006, but were subject to
shareholder approval of the amendment and restatement of the 2004 Stock Incentive Plan, which
increased the number of shares available for grant under the Plan. Shareholder approval was
obtained at our annual meeting of shareholders held on December 1, 2006. |
|
(2) |
|
The Remuneration Committee approved a cash incentive plan providing for a payment of 100% of
annual base salary, or $725,000, if the following quantitative and qualitative requirements were
met by Dr. Belamant during our fiscal 2007 year: |
Quantitative: 60% of the cash incentive award based on pure EPS growth of 20% 25% (after
reversing the stock-based compensation charge, amortization of intangible assets and costs
related to an acquisition that we ultimately decided not to pursue) with a weighting between
USD and ZAR, respectively, being 60%/40%.
Qualitative: 40% of the cash incentive award was awarded at
the discretion of the Remuneration Committee
having regard to the following:
|
|
|
achievement of operational milestones; |
|
|
|
|
integration of key staff; |
|
|
|
|
appointment of a chief operating officer; and |
|
|
|
|
further international progress. |
The achievement of the qualitative requirement only represents the minimum amount payable
(Threshold $000) for a certain level of performance. Our Remuneration Committee determined that
Dr. Belamant satisfied the quantitative requirements and that the qualitative requirements had been
sufficiently achieved to justify his full cash incentive award which was paid in September 2007.
19
(3) |
|
The Remuneration Committee approved a cash incentive plan providing for a payment of 75% of
base annual salary, or $350,000, if the following quantitative and qualitative requirements were
met by Mr. Kotzé during our fiscal 2007 year: |
Quantitative: 70% of the cash incentive award based on pure EPS growth of 20% 25% (after
reversing the stock-based compensation charge, amortization of intangible assets and costs
related to an acquisition that we ultimately decided not to pursue) with a weighting between
USD and ZAR, respectively, being 60%/40%.
Qualitative: 30% of the cash incentive award was awarded at the discretion of the Remuneration Committee having
regard to the following:
|
|
|
integration of Prism senior accounting into our operations; and |
|
|
|
|
performance of such tasks as Dr. Belamant may reasonably require. |
The achievement of the qualitative requirement only represents the minimum amount payable
(Threshold $000) for a certain level of performance. Our Remuneration Committee determined that
Mr. Kotzé met all quantitative and qualitative requirements and his full cash incentive award was
paid in September 2007.
(4) |
|
Represents the grant date fair value of stock options granted on August 24, 2006 computed in
accordance with FAS 123R. |
|
(5) |
|
The exercise price of these option awards differs from the closing market price on the date of
grant. The exercise price was determined based on the average of the high and low price of our
common stock on the date of grant. |
The stock options granted in August 2006 have a ten-year term and vest in 20% increments on
May 8th of 2007, 2008, 2009, 2010 and 2011, so long as the recipient remains employed with us
through the applicable vesting date. In determining the vesting dates of equity-based awards
granted in 2006, the Remuneration Committee was mindful of current South African tax law, which
applies to substantially all of our employees, and which subjects employees to taxation when their
options become exercisable, regardless of whether the options have been exercised. Therefore, the
Remuneration Committee believes that it is important to provide employees, especially non-executive
officer employees, with the ability to exercise their options and sell the underlying shares
shortly after vesting in order to provide the employees with cash to pay their income taxes.
However, since most non-executive officer employees do not as a practical matter have access to
brokers who can assist them in a sale of their shares, the Remuneration Committee believes that it
would be beneficial for employees if we were to facilitate annual block trades of shares acquired
upon exercise. Thus, the Remuneration Committee selected May 8 as the annual vesting date because
it was anticipated to be several days after release of our third quarter earnings report and
therefore, sales of shares at or about that time would not be subject to restrictions on trading
under our insider trading policy.
20
In August 2007, the Remuneration Committee approved grants of 591,500 shares of restricted
stock (145,000 shares of which were granted to the executive officers). The primary purpose of
these grants was to encourage retention and reward our positive financial performance. One-third
of the award shares will vest on each of September 1, 2009, 2010 and 2011. Vesting of the award
shares is conditional upon each recipients continuous service through the applicable vesting date
and our achieving the financial performance target set for that vesting date. Specifically, the
financial performance targets were set based on a 20% increase, compounded annually, in fundamental
earnings per share (diluted) (expressed in South African rand) above the fundamental EPS for the
fiscal year ended June 30, 2007; provided, however, that in the case of Dr. Belamant and Mr. Kotzé,
the annual required increase is 25% rather than 20%. For this purpose, fundamental EPS are
calculated by adjusting GAAP earnings per share (diluted) (as reflected in our audited consolidated
financial statements) to exclude the effects related to the amortization of intangible assets,
stock-based compensation charges, one-time, large, unusual expenses as determined in the discretion
of the Remuneration Committee, and assuming a constant tax rate of 30%. If the fundamental EPS for
the specified fiscal year does not equal or exceed the fundamental EPS target for such year, no
award shares will vest or become nonforfeitable on the corresponding vesting date. Any award
shares that do not vest and become nonforfeitable because the fundamental EPS target is not met for
the specified fiscal year remain outstanding and are available to vest and become nonforfeitable as
of a subsequent vesting date if the fundamental EPS target for a subsequent fiscal year is met;
provided that the recipients service continues through such subsequent vesting date. Any
outstanding award shares that have not vested and become nonforfeitable as of September 1, 2011,
will be forfeited by the recipient on September 1, 2011 and transferred to us for no consideration.
The fundamental EPS targets will be proportionately adjusted by the Remuneration Committee for
any stock split, reverse stock split, stock dividend, share combination, recapitalization or
similar event effected subsequent to the date of grant. The Remuneration Committee, in its sole
discretion, may adjust the targets as it considers in good faith to be appropriate to reflect
extraordinary items including, without limitation, the charges or costs associated with our
restructuring, discontinued operations, other unusual or nonrecurring items, and the cumulative
effects of accounting changes.
21
OUTSTANDING EQUITY AWARDS AT 2007 FISCAL YEAR-END
The following table shows all outstanding equity awards held by our named executive officers
at the end of fiscal 2007. The market value of unvested shares reflected in this table is
calculated by multiplying the number of unvested shares by the closing price of US$24.15 of our
common stock on June 29, 2007, the last trading day of the fiscal year.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number |
|
Incentive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of |
|
Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
Market |
|
|
Number of |
|
Securities |
|
Awards: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of |
|
|
Securities |
|
Under- |
|
Number of |
|
|
|
|
|
|
|
|
|
Number |
|
Shares or |
|
|
Underlying |
|
lying |
|
Securities |
|
|
|
|
|
|
|
|
|
of Shares |
|
Units of |
|
|
Unexer- |
|
Unexer- |
|
Underlying |
|
|
|
|
|
|
|
|
|
or Units |
|
Stock |
|
|
cised |
|
cised |
|
Unexer- |
|
Option |
|
|
|
|
|
of Stock |
|
That |
|
|
Options (#) |
|
Options |
|
cised |
|
Exercise |
|
Option |
|
That |
|
Have Not |
|
|
Exercisable |
|
(#) |
|
Unearned |
|
Price |
|
Expiration |
|
Have Not |
|
Vested |
Name |
|
(1) |
|
Unexercisable |
|
Options (#) |
|
($) |
|
Date |
|
Vested |
|
($000) |
Dr. Serge
Belamant |
|
|
16,666 |
|
|
|
16,670 |
|
|
|
n/a |
|
|
$ |
3.00 |
|
|
|
6/7/2014 |
|
|
|
16,670 |
|
|
|
403 |
|
|
|
|
16,000 |
|
|
|
64,000 |
|
|
|
n/a |
|
|
$ |
22.51 |
|
|
|
8/24/2016 |
|
|
|
64,000 |
|
|
|
1,546 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Herman Kotzé |
|
|
16,666 |
|
|
|
16,670 |
|
|
|
n/a |
|
|
$ |
3.00 |
|
|
|
6/7/2014 |
|
|
|
16,670 |
|
|
|
403 |
|
|
|
|
7,000 |
|
|
|
28,000 |
|
|
|
n/a |
|
|
$ |
22.51 |
|
|
|
8/24/2016 |
|
|
|
28,000 |
|
|
|
676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brenda Stewart |
|
|
16,666 |
|
|
|
16,670 |
|
|
|
n/a |
|
|
$ |
3.00 |
|
|
|
6/7/2014 |
|
|
|
16,670 |
|
|
|
403 |
|
|
|
|
5,000 |
|
|
|
20,000 |
|
|
|
n/a |
|
|
$ |
22.51 |
|
|
|
8/24/2016 |
|
|
|
20,000 |
|
|
|
483 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nitin Soma |
|
|
16,666 |
|
|
|
16,670 |
|
|
|
n/a |
|
|
$ |
3.00 |
|
|
|
6/7/2014 |
|
|
|
16,670 |
|
|
|
403 |
|
|
|
|
4,000 |
|
|
|
16,000 |
|
|
|
n/a |
|
|
$ |
22.51 |
|
|
|
8/24/2016 |
|
|
|
16,000 |
|
|
|
386 |
|
|
|
|
(1) |
|
The remaining $3.00 options vest on June 7, 2008 and the remaining
$22.51 options vest in 20% increments on May 8, 2008, 2009, 2010 and
2011, respectively. |
OPTIONS EXERCISED AND STOCK VESTED
The following table shows all stock options exercised and value realized upon exercise, and
all stock awards vested and value realized upon vesting, by the named executive officers during
fiscal 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options |
|
Stock awards |
|
|
Number of Shares |
|
|
|
|
|
Number of Shares |
|
|
|
|
Acquired on |
|
Value |
|
Acquired on |
|
Value |
|
|
Exercise |
|
Realized on |
|
Vesting |
|
Realized on |
Name |
|
(#) |
|
Exercise ($000) |
|
(#) |
|
Vesting ($) |
Dr. Serge Belamant |
|
|
|
|
|
|
|
|
|
|
n/a |
|
|
|
n/a |
|
|
Herman Kotzé |
|
|
|
|
|
|
|
|
|
|
n/a |
|
|
|
n/a |
|
|
Brenda Stewart |
|
|
|
|
|
|
|
|
|
|
n/a |
|
|
|
n/a |
|
|
Nitin Soma |
|
|
16,666 |
|
|
|
339 |
|
|
|
n/a |
|
|
|
n/a |
|
22
POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE-IN-CONTROL
As described above under Compensation Discussion and Analysis, we do not have employment,
severance or change of control agreements with our employees, including the executive officers.
Accordingly, there would be no compensation, other than that prescribed by local labor laws in the
case of unfair dismissal or retrenchment, that would become payable under the existing plans and
arrangements if the employment of any of our executive officers had terminated on June 30, 2007.
We do not have any on-going obligation to provide post-termination benefits to our employees after
termination of employment.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Review and Approval of Related Person Transactions
We review all relationships and transactions in which we and our directors and executive
officers or their immediate family members are participants to determine whether such persons have
a direct or indirect material interest. Our management is primarily responsible for the development
and implementation of processes and controls to obtain information from the directors and executive
officers with respect to related person transactions and for then determining, based on the facts
and circumstances, whether we or a related person has a direct or indirect material interest in the
transaction. As required under SEC rules, transactions that are determined to be directly or
indirectly material to us or a related person are disclosed in our proxy statement. In addition,
our Audit Committee reviews and approves or ratifies any related person transaction that is
required to be disclosed. In the course of its review and approval or ratification of a disclosable
related party transaction, our Audit Committee considers:
|
|
|
the nature of the related persons interest in the transaction; |
|
|
|
|
the material terms of the transaction, including, without limitation, the amount and
type of transaction; |
|
|
|
|
the importance of the transaction to the related person; |
|
|
|
|
the importance of the transaction to us; |
|
|
|
|
whether the transaction would impair the judgment of a director or executive officer to
act in our best interest; and |
|
|
|
|
any other matters the committee deems appropriate. |
Any member of the Audit Committee who is a related person with respect to a transaction under
review may not participate in the deliberations or vote respecting approval or ratification of the
transaction, provided, however, that such director may be counted in determining the presence of a
quorum at a meeting of the committee that considers the transaction.
Related Party Transactions
Pursuant to the common stock purchase agreement, dated January 30, 2004, between us and SAPEF,
SAPEF is entitled to designate three nominees to our Board. SAPEF has informally agreed to reduce
the number of its designated nominees from three to two due to the recent reduction in the number
of our shares that SAPEF holds. Messrs. Ball and Pein currently serve on our Board as SAPEFs
designees.
23
Pursuant to the stock purchase agreement, dated July 18, 2005, among the investment entities
affiliated with GA, us and certain other parties, GA is entitled to designate one nominee to our
Board. This designee is currently Mr. Wendelstadt. In addition, pursuant to the stock purchase
agreement, we granted rights, under certain circumstances and subject to certain limitations, with
respect to the registration of our shares held by investment entities affiliated with GA.
We are currently negotiating a registration rights agreement with SAPEF and GA.
AUDIT AND NON-AUDIT FEES
The following table shows the fees that we paid or accrued for the audit and other services
provided by Deloitte for the years ended June 30, 2007 and 2006.
|
|
|
|
|
|
|
|
|
|
|
Year ended June 30, |
|
|
2007 |
|
2006 |
|
|
$ 000 |
|
$ 000 |
Audit Fees |
|
|
1,289 |
|
|
|
1,529 |
|
Audit-Related Fees |
|
|
|
|
|
|
|
|
Tax Fees |
|
|
|
|
|
|
22 |
|
All Other Fees |
|
|
|
|
|
|
|
|
Audit Fees This category includes the audit of our annual consolidated financial statements,
review of financial statements included in our quarterly reports on Form 10-Q, the Sarbanes-Oxley
Act of 2002 required audit of managements assessment of the effectiveness of our internal control
over financial reporting and the auditors independent audit of internal control over financial
reporting, and the services that an independent auditor would customarily provide in connection
with subsidiary audits, statutory requirements, regulatory filings, and similar engagements for the
fiscal year, such as comfort letters, attest services, consents, and assistance with review of
documents filed with the SEC. This category also includes advice on audit and accounting matters
that arose during, or as a result of, the audit or the review of interim financial statements.
Audit-Related Fees This category consists of assurance and related services by the
independent registered public accounting firm that are reasonably related to the performance of the
audit or review of our financial statements and are not reported above under Audit Fees. There
were no such fees paid in the years ended June 30, 2007 or 2006.
Tax Fees This category consists of professional services rendered by Deloitte for tax
compliance and tax advice. The services for the fees disclosed under this category include tax
return review and technical tax advice. There were no such fees paid in the year ended June 30,
2007.
All Other Fees There were no such fees paid in the year ended June 30, 2007 or 2006.
Pre-Approval of Non-Audit Services
Pursuant to our Audit Committee charter, our Audit Committee reviews and pre-approves both
audit and non-audit services to be provided by our independent auditors. The authority to grant
pre-approvals of non-audit services may be delegated to one or more designated members of the Audit
Committee whose decisions will be presented to the full Audit Committee at its next regularly
scheduled meeting. During fiscal 2007, all of the audit, audit-related, tax and other services
provided by Deloitte with respect to fiscal year 2007 were pre-approved by the Board and the Audit
Committee.
24
AUDIT COMMITTEE REPORT
The Audit Committee of the Board consists of three independent directors, as required by
Nasdaq listing standards. The Audit Committee operates under a written charter adopted by the Board
and available on our website at www.net1ueps.com. The Audit Committee is responsible for
overseeing our financial reporting process on behalf of the Board. The members of the Audit
Committee are Messrs. Seabrooke, Pein and Edwards. The committee selects, subject to shareholder
ratification, our independent registered public accounting firm.
Management is responsible for our financial statements and the financial reporting process,
including internal controls. The independent registered public accounting firm is responsible for
performing an independent audit of our consolidated financial statements in accordance with
auditing standards generally accepted in the United States and of our internal control over
financial reporting and for issuing a report thereon. The committees responsibility is to monitor
and oversee these processes.
In this context, the Audit Committee has met and held discussions with management and Deloitte
& Touche (South Africa), or Deloitte, our independent registered public accounting firm. Management
represented to the Audit Committee that the consolidated financial statements were prepared in
accordance with accounting principles generally accepted in the United States, and the committee
reviewed and discussed the consolidated financial statements with management and Deloitte. The
Audit Committee discussed with Deloitte the matters required to be discussed by Statement on
Auditing Standards No. 61 (Codification of Statements of Auditing Standards AU §380), as may be
modified or supplemented. These matters included a discussion of Deloittes judgments about the
quality (not just the acceptability) of our accounting principles as applied to our financial
reporting.
Deloitte also provided the Audit Committee with the written disclosures and letter required by
Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees), and
the Audit Committee discussed with Deloitte the firms independence. The committee further
considered whether the provision by Deloitte of the non-audit services described above is
compatible with maintaining the auditors independence.
Based upon the Audit Committees discussion with management and Deloitte and the Audit
Committees review of the representations of management and the disclosures by Deloitte to the
Audit Committee, the committee recommended to the Board that our audited consolidated financial
statements be included in our Annual Report on Form 10-K for the year ended June 30, 2007, for
filing with the SEC.
|
|
|
|
|
|
|
Audit Committee
|
|
|
|
|
|
|
|
|
|
Christopher S. Seabrooke, Chairman |
|
|
|
|
Alasdair J. K. Pein |
|
|
|
|
Paul Edwards |
|
|
25
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
The following table presents, as of October 19, 2007, information about beneficial ownership
of our common stock by:
|
|
|
each person or group of affiliated persons who or which, to our knowledge, owns
beneficially more than 5% of our outstanding shares of common stock; |
|
|
|
|
each of our directors and named executive officers; and |
|
|
|
|
all of our directors and executive officers as a group. |
Beneficial ownership of shares is determined in accordance with SEC rules and generally
includes any shares over which a person exercises sole or shared voting or investment power. The
beneficial ownership percentages set forth below are based on 52,339,194 shares of common stock and
5,389,140 shares of special convertible preferred stock outstanding as of October 19, 2007. All
shares of common stock into which any named person can cause to be converted their special
convertible preferred stock and all shares of common stock underlying stock options that are
presently exercisable or exercisable within 60 days after October 19, 2007 by each person are
deemed to be outstanding and beneficially owned by that person for the purpose of computing the
ownership percentage of that person, but are not considered outstanding for the purpose of
computing the percentage ownership of any other person. Each share of our outstanding special
convertible preferred stock votes together with our common stock on a one vote per share basis.
Voting power percentage is based on an aggregate 57,728,334 shares of common stock and special
convertible preferred stock outstanding as of October 19, 2007.
Unless otherwise indicated, to our knowledge, each person listed in the table below has sole
voting and investment power with respect to the shares shown as beneficially owned by such person,
except to the extent applicable law gives spouses shared authority. Except as otherwise noted, each
shareholders address is c/o Net 1 UEPS Technologies, Inc., President Place, 4th Floor, Cnr. Jan
Smuts Avenue and Bolton Road, Rosebank, Johannesburg, South Africa.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of Common |
|
Voting |
|
|
Stock Beneficially Owned |
|
power |
Name |
|
Number |
|
% |
|
% |
Antony C. Ball(1) |
|
|
16,666 |
|
|
|
* |
|
|
|
* |
|
Dr. Serge C.P Belamant(2) |
|
|
2,174,287 |
|
|
|
4.1 |
% |
|
|
3.8 |
% |
Paul Edwards(1) |
|
|
16,666 |
|
|
|
* |
|
|
|
* |
|
Herman G. Kotzé(3) |
|
|
213,665 |
|
|
|
* |
|
|
|
* |
|
Alasdair J.K. Pein(1) |
|
|
16,666 |
|
|
|
* |
|
|
|
* |
|
Chris S. Seabrooke(1) |
|
|
16,666 |
|
|
|
* |
|
|
|
* |
|
Brenda L. Stewart(4) |
|
|
123,332 |
|
|
|
* |
|
|
|
* |
|
Nitin Soma(5) |
|
|
167,332 |
|
|
|
* |
|
|
|
* |
|
Florian P. Wendelstadt(6) |
|
|
6,409,091 |
|
|
|
12.2 |
% |
|
|
11.1 |
% |
Investment entities affiliated with Brait S.A.(7) |
|
|
9,387,984 |
|
|
|
17.9 |
% |
|
|
16.3 |
% |
Investment entities affiliated with General
Atlantic LLC(6) |
|
|
6,409,091 |
|
|
|
12.2 |
% |
|
|
11.1 |
% |
Gilder, Gagnon, Howe & Co. LLC(8) |
|
|
2,652,106 |
|
|
|
5.1 |
% |
|
|
4.6 |
% |
Brookside Capital Partners Fund, L.P.(9) |
|
|
2,701,290 |
|
|
|
5.2 |
% |
|
|
4.7 |
% |
Directors and Executive Officers as a group
(9 persons)(10) |
|
|
9,154,371 |
|
|
|
17.1 |
% |
|
|
15.9 |
% |
26
|
|
|
(1) |
|
Each of Messrs. Ball and Seabrooke beneficially owns options to
purchase 25,001 shares of common stock, of which options to purchase
16,666 shares are currently exercisable. Each of Messrs. Edwards and
Pein beneficially owns options to purchase 16,666 shares of common
stock, of which options to purchase 8,333 shares are currently
exercisable. |
|
(2) |
|
CI Law Trustees Limited for the San Roque Trust dated 8/18/92 owns
800,799 shares of common stock. Dr. Serge C.P. Belamant as proxy of CI
Law Trustees has the power to vote all of CI Law Trustees shares. The
remaining 1,373,488 shares are owned directly by Dr. Belamant and
include (i) 166,666 shares of common stock (66,667 of which may be
not be sold until May 8, 2008), (ii) 16,000 stock options which became
exercisable on May 8, 2007, (iii) 40,000 restricted stock awards
approved by the Remuneration Committee pursuant to the Amended and
Restated 2004 Stock Incentive Plan which are subject to the
satisfaction of certain vesting conditions related to our financial
performance and Dr. Belamants continuous employment or service with
us, one-third of the shares will vest on each of September 1, 2009,
2010 and 2011 and (iv) 1,150,822 shares of special convertible
preferred stock beneficially owned by Dr. Belamant that are
convertible into common stock upon the occurrence of a trigger event.
Does not include 80,670 shares of common stock underlying stock
options, which are not exercisable and will not become exercisable
within 60 days after October 19, 2007. |
|
(3) |
|
Includes 206,665 shares of common stock and 7,000 stock options which
became exercisable on May 8, 2007. The number of shares of common
stock includes 66,667 shares of common stock which may not be sold
until May 8, 2008 and 40,000 restricted stock awards approved by the
Remuneration Committee pursuant to the Amended and Restated 2004 Stock
Incentive Plan which are subject to the satisfaction of certain
vesting conditions related to our financial performance and Mr.
Kotzés continuous employment or service with us, one-third of the
shares will vest on each of September 1, 2009, 2010 and 2011. Does not
include 44,670 shares of common stock underlying stock options which
are not exercisable and will not become exercisable within 60 days
after October 19, 2007. |
|
(4) |
|
Includes 101,666 shares of common stock, 5,000 stock options which
became exercisable on May 8, 2007 and 16,666 stock options which
became exercisable on June 7, 2007. The number of shares of common
stock includes 66,666 shares of common stock which may not be sold
until May 8, 2008 and 35,000 restricted stock awards approved by the
Remuneration Committee pursuant to the Amended and Restated 2004 Stock
Incentive Plan which are subject to the satisfaction of certain
vesting conditions related to our financial performance and Ms.
Stewarts continuous employment or service with us, one-third of the
shares will vest on each of September 1, 2009, 2010 and 2011. Does not
include 36,670 shares of common stock underlying stock options which
are not exercisable and will not become exercisable within 60 days
after October 19, 2007. |
|
(5) |
|
Includes 163,332 shares of common stock and 4,000 stock options which
became exercisable on May 8, 2007. The number of shares of common
stock includes 50,000 shares of common stock which may not be sold
until May 8, 2008 and 30,000 restricted stock awards approved by the
Remuneration Committee pursuant to the Amended and Restated 2004 Stock
Incentive Plan which are subject to the satisfaction of certain
vesting conditions related to our financial performance and Mr. Somas
continuous employment or service with us, one-third of the shares will
vest on each of September 1, 2009, 2010 and 2011. Does not include
32,670 shares of common stock underlying stock options which are not
exercisable and will not become exercisable within 60 days after
October 19, 2007. |
27
|
|
|
(6) |
|
According to Amendment No. 1 to Schedule 13D, dated June 22, 2006,
filed by General Atlantic LLC (GA), and its affiliates, General
Atlantic Partners 80, L.P. (GAP 80), General Atlantic Partners 82,
L.P. (GAP 82), GapStar, LLC (GapStar), GAP Coinvestments III,
LLC, (GAPCO III), GAP Coinvestments IV, LLC, (GAPCO IV), GAPCO
GmbH & Co. KG (KG), GAPCO Management GmbH, (GmbH Management), and
GAP Coinvestments CDA, L.P. (GAPCO CDA) and supplemental
information provided to us by GA, these entities beneficially own, in
the aggregate, 6,409,091shares of common stock. GA is the general
partner of GAP 80, GAP 82 and GAPCO CDA. GA is also the sole member
of GapStar. GmbH Management is the general partner of KG. The
Managing Directors of GA are Steven A. Denning (Chairman), William E.
Ford Chief Executive Officer), H. Raymond Bingham, Peter L. Bloom,
Mark F. Dzialga, Klaus Esser, Vince Feng, William O. Grabe, Abhay
Havaldar, David C. Hodgson, Rene M. Kern, Jonathan Korngold,
Christopher G. Lanning, Jeff Leng, Anton J. Levy, Marc F. McMorris,
Thomas J. Murphy, Matthew Nimetz, Ranjit Pandit, Andrew C. Pearson,
Raul Rai, David A. Rosenstein, Sunish Sharma, Franchon M. Smithson,
Oliver Thum, Tom C. Tinsley, Sean Tong, Philip P. Trahanas and
Florian P. Wendelstadt (collectively, the GA Managing Directors).
Mr. Wendelstadt is a director of the Company. The managing members of
GAPCO III and GAPCO IV are GA Managing Directors. The business
address of each of the GA Managing Directors (other than Messrs.
Esser, Feng, Leng, Tong, Havaldar, Pandit, Rai, Sharma, Thum,
Tinsley, Wendelstadt, Bingham and McMorris) is 3 Pickwick Plaza,
Greenwich, Connecticut 06830. The business address of Messrs. Esser
and Thum is Koenigsallee 62, 40212, Duesseldorf, Germany. The
business address of Messrs. Feng, Leng and Tong is Suite 2007-10, One
International Finance Centre, 1 Harbour View Street, Central, Hong
Kong. The business address of Messrs. Havaldar, Pandit, Rai and
Sharma is Room 151, 152 Maker Chambers VI, Naisman Point, Mumbai 400
021, India. The business address of Messrs. Bingham and McMorris is
228 Hamilton Avenue, Palo Alto, California 94301. The business
address of Mr. Tinsley is 2401 Pennsylvania Avenue NW, Washington DC
20037. |
|
(7) |
|
According to Amendment No. 2 to Schedule 13D, dated June 22, 2006,
filed by South African Private Equity Fund III, L.P., SAPEF III
International G.P. Limited, Capital Partners Group Holdings Limited
and Brait, S.A., these entities beneficially own in the aggregate
9,387,984 shares of common stock, which includes 166,458 shares of
special convertible preferred stock. The address and principal
place of business of each of SAPEF III Fund and SAPEF G.P. is Walker
House, P.O. Box 908, George Town, Grand Cayman, Cayman Islands. The
address and principal place of business of Capital Partners is Abbott
Building, P.O. Box 3186, Road Town, Tortola, British Virgin Islands.
The address and principal place of business of Brait S.A. is 180 rue
des Aubepines, L-1145, Luxembourg. |
|
(8) |
|
According to a Schedule 13G, dated August 31, 2005, filed by Gilder,
Gagnon, Howe & Co. LLC, Gilder beneficially owns 2,652,106 shares of
common stock. The shares reported include 2,372,704 shares held in
customer accounts over which partners and/or employees of Gilder have
discretionary authority to dispose of or direct the disposition of
the shares, 245,380 shares held in accounts owned by the partners of
Gilder and their families, and 34,022 shares held in the account of
the profit-sharing plan of Gilder. Gilders principal business
address is 1775 Broadway, 26th Floor, New York, NY 10019. |
|
(9) |
|
According to a Schedule 13G, dated February 14, 2007, filed by
Brookside Capital Partners Fund L.P., Brookside beneficially owns
2,701,290 shares of common stock. The shares reported include
2,372,704 shares held in customer accounts over which partners and/or
employees of Gilder have discretionary authority to dispose of or
direct the disposition of the shares, 245,380 shares held in accounts
owned by the partners of Gilder and their families, and 34,022 shares
held in the account of the profit-sharing plan of Gilder. The shares
reported include 2,701,290 shares of Common Stock owned by the
Brookside Fund. The Brookside Fund acts by and through its general
partner, Brookside Investors. Brookside Investors acts by and through
its general partner, Brookside Management. Mr. Domenic J. Ferrante is
the managing member of Brookside Management and thus is the
controlling person of Brookside Management. Brooksidess principal
business address is 111 Huntington Avenue, Boston, Massachusetts
02199. |
|
(10) |
|
Includes 1,150,822 shares of special convertible preferred stock.
Also includes 145,000 restricted stock awards approved by the
Remuneration Committee pursuant to the Amended and Restated 2004
Stock Incentive Plan which are subject to the satisfaction of certain
vesting conditions related to our financial performance and the
executives continuous employment or service with us, one-third of
the shares will vest on each of September 1, 2009, 2010 and 2011.
Does not include 194,680 shares of common stock underlying stock
options, which are not exercisable and will not become exercisable
within 60 days after October 19, 2007. |
28
ADDITIONAL INFORMATION
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires that our executive officers and directors, and
persons who own more than ten percent of a registered class of our equity securities, file reports
of ownership and changes in ownership with the SEC and provide us with copies of such reports. We
have reviewed such reports received by us and written representations from our directors and
executive officers. Based solely on such review, we identified one filing that was not made on a
timely basis. Brenda L. Stewart was late in filing one Form 4 for the receipt of stock options.
Other Matters
Our Board knows of no other business that will be presented for consideration at the annual
meeting. Return of a valid proxy, however, confers on the designated proxy holders discretionary
authority to vote the shares in accordance with their best judgment on such other business, if any,
that may properly come before the annual meeting or any adjournment or postponement thereof. It is
important that the proxies be returned promptly and that your shares be represented. You are urged
to sign, date and promptly return the enclosed proxy card in the enclosed envelope.
Annual Report on Form 10-K
A copy of our annual report on Form 10-K (without exhibits) for the fiscal year ended June 30,
2007 is being distributed along with this proxy statement. We refer you to such report for
financial and other information about us, but such report is not incorporated in this proxy
statement and is not deemed to be a part of the proxy solicitation material. It is also available
on our website (www.net1ueps.com). In addition, the report (with exhibits) is available at
the SECs website (www.sec.gov).
Shareholder Proposals for the 2008 Annual Meeting
Qualified shareholders who wish to have proposals presented at the 2008 annual meeting of
shareholders must deliver them to us by July 2, 2008, in order to be considered for inclusion in
next years proxy statement and proxy pursuant to Rule 14a-8 under the Exchange Act.
Any shareholder proposal or director nomination for our 2008 annual meeting that is submitted
outside the processes of Rule 14a-8 will be considered untimely if we receive it after July 2,
2008. Such proposals and nominations must be made in accordance with Section 2.08 of our Amended
and Restated By-Laws. An untimely proposal may be excluded from consideration at our 2007 annual
meeting. All proposals and nominations must be delivered to us at our principal executive offices
at P O Box 2424, Parklands 2121, Gauteng, South Africa.
|
|
|
|
|
|
|
By Order of the Board of Directors, |
|
|
|
|
|
|
|
|
|
Dr. Serge C. P. Belamant
|
|
|
|
|
Chairman and Chief Executive Officer |
|
|
October 26, 2007
THE BOARD HOPES THAT YOU WILL ATTEND THE MEETING. WHETHER OR NOT YOU PLAN TO ATTEND, PLEASE
PROMPTLY COMPLETE, DATE, SIGN AND RETURN THE ENCLOSED PROXY.
29
NET 1 UEPS TECHNOLOGIES, INC.
PROXY
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS |
This proxy is solicited on behalf of the Board of Directors of Net 1 UEPS Technologies, Inc.
for the Annual Meeting of Shareholders to be held on November 30, 2007. The undersigned appoints
Dr. Serge C.P. Belamant and Herman G. Kotzé, and each of them, with full power of substitution in
each, the proxies of the undersigned, to represent the undersigned and vote all shares of the
common stock of Net 1 UEPS Technologies, Inc. which the undersigned may be entitled to vote at the
Annual Meeting of Shareholders to be held on November 30, 2007, and at any adjournment or
postponement thereof, as indicated on the reverse side of this proxy. |
This proxy, when properly executed, will be voted in the manner directed herein by the
undersigned shareholder. If no direction is given, then this proxy will be voted FOR ALL nominees
for director and FOR proposal 2. |
Address Change
___Net 1 UEPS Technologies, Inc.
___P.O. BOX 11057
___NEW YORK, N.Y. 10203-0057 |
? DETACH PROXY CARD HERE ? |
___Mark, Sign, Date and Return X
___this Proxy Card Promptly
___Using the Enclosed Envelope. |
Votes must be indicated
(x) in Black or Blue ink. |
THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR ALL NOMINEES FOR
DIRECTOR AND FOR PROPOSAL 2. |
1. ELECTION OF DIRECTORS: |
FOR ALL WITHHOLD FOR ALL EXCEPTIONS To change your address, please mark
this box and provide new address
where indicated on the reverse side
of this Proxy Card. |
Nominees: Dr. Serge C.P. Belamant, Herman G. Kotzé, Christopher S. Seabrooke, Antony C. Ball, Alasdair J.K. Pein, Paul Edwards and Florian P. To include any comments, please mark
Wendelstadt this box. |
INSTRUCTION: To withhold authority to vote for any individual nominee, write that nominees name in the following space: |
2. PROPOSAL TO RATIFY THE SELECTION OF DELOITTE & TOUCHE (SOUTH AFRICA) AS THE INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE 2008 FISCAL YEAR. |
3. In their discretion upon such other matters as may properly come before the meeting. |
Please sign exactly as your name appears on your stock certificates. When joint tenants hold shares, both
should sign. When signing as attorney, executor, administrator, trustee, guardian, please give full title
as such. If a corporation, please sign in full corporate name by president or other authorized officer. If
a partnership, please sign in partnership name by authorized person. |
Shareholder sign here Date Co-Owner sign here
Date |